zika
viru
zikv
mosquitoborn
flaviviru
lead
birth
defect
microcephali
ocular
lesion
neurolog
disord
syndrom
licens
vaccin
antivir
treatment
zikv
infect
effort
understand
complex
interact
zikv
cellular
network
contribut
identif
novel
hostdirect
antivir
hda
candid
among
cellular
pathway
involv
infect
lipid
metabol
gain
attent
zikvinfect
cell
lipid
metabol
attribut
intracellular
membran
remodel
virion
morphogenesi
autophagi
modul
innat
immun
inflamm
key
role
play
cellular
structur
associ
lipid
metabol
peroxisom
lipid
droplet
start
deciph
consequ
wide
varieti
lipidrel
antivir
strategi
current
consider
includ
inhibit
sterol
regulatori
elementbind
protein
srebp
activ
adenosinemonophosph
activ
kinas
ampk
inhibit
acetylcoenzym
carboxylas
acc
interfer
sphingolipid
metabol
blockag
intracellular
cholesterol
traffick
treatment
cholesterol
deriv
remark
hda
identifi
studi
also
effect
flavivirus
zikv
west
nile
viru
dengu
viru
support
broadspectrum
effect
consid
lipid
metabol
one
main
cellular
pathway
suitabl
pharmacolog
intervent
idea
reposit
drug
target
lipid
metabol
antivir
candid
gain
forc
pharmaceut
nervou
tissu
current
two
major
line
investig
develop
antivir
zikv
search
direct
act
antivir
daa
base
interfer
viral
compon
eg
inhibitor
fusion
viral
proteas
rna
depend
rna
polymeras
ii
identif
hostdirect
antivir
hda
inhibit
host
factor
coopt
viru
complet
infecti
cycl
theoret
hda
carri
advantag
less
prone
select
resist
mutant
could
lead
identif
broadspectrum
antivir
effect
taxonomicallyrel
virus
last
year
knowledg
virushost
interact
exponenti
grown
reveal
life
cycl
mani
virus
includ
zikv
depend
upon
host
lipid
metabol
valuabl
inform
unveil
potenti
antivir
target
start
explor
expect
detail
knowledg
metabol
alter
eg
lipid
metabol
zikv
arbovir
infect
could
help
design
novel
therapeut
also
use
identif
molecular
biomark
suitabl
improv
diagnost
review
summar
princip
find
current
statu
progress
develop
drug
interfer
lipid
metabol
function
antivir
zikv
zika
viru
zikv
human
pathogen
transmit
mosquito
caught
major
attent
associ
neonat
malform
ie
microcephali
brazil
howev
consequ
zikv
infect
limit
pregnant
women
newborn
viru
also
induc
wide
rang
symptom
go
fever
rash
headach
joint
muscl
pain
conjunct
sever
ocular
lesion
neurolog
disord
like
syndrom
rapid
expans
zikv
across
america
led
world
health
organ
declar
public
health
emerg
intern
concern
februari
sinc
great
effort
perform
develop
effect
control
mechan
instanc
prophylact
prevent
vaccin
develop
even
undergon
clinic
trial
anoth
front
line
defens
combat
pathogen
develop
antivir
therapi
still
specif
antivir
therapi
licens
treatment
zikv
infect
antivir
develop
zikv
face
specif
challeng
safeti
pregnant
women
abil
drug
cross
bloodbrain
barrier
bbb
combat
infect
zikv
member
genu
flaviviru
within
famili
flavivirida
genu
includ
speci
positivesens
singlestrand
rna
virus
includ
import
pathogen
dengu
viru
denv
west
nile
viru
wnv
genom
kb
length
encod
singl
open
read
frame
translat
viral
polyprotein
polyprotein
undergo
cotransl
posttransl
proteolyt
cleavag
viral
host
proteas
produc
matur
protein
three
structur
protein
c
capsid
membran
e
envelop
seven
nonstructur
protein
notabl
major
structur
nonstructur
protein
zikv
exhibit
transmembran
domain
even
contain
transmembran
sequenc
associ
cellular
membran
interact
viral
protein
lipid
import
complet
differ
aspect
zikv
lifecycl
remark
relev
lipid
infect
figur
describ
denv
wnv
omic
approach
confirm
zikv
infect
alter
signific
number
lipid
metabolit
suggest
metabolit
key
player
infect
specif
analys
lipidom
transcriptom
profil
zikvinfect
cell
differ
origin
microglia
mosquito
primari
retin
pigment
epithelium
reveal
zikv
infect
markedli
modul
lipid
metabol
remodel
host
lipid
metabol
modul
express
sphingolipid
like
ceramid
sphingomyelin
glycerophospolipid
phosphoglycerid
phosphatidylcholin
phosphatidylserin
plasmenylphosphatidylethanolamin
also
name
plasmalogen
lysophospholipid
lysophosphatidylcholin
di
carboxyl
acid
undecanedio
dodecanedio
acid
although
case
role
infect
lipid
still
undefin
would
presum
involv
key
process
go
virion
biogenesi
membran
remodel
genom
replic
neuron
differenti
regul
autophagi
apoptosi
involv
lipid
flaviviru
biolog
begin
step
virion
morphogenesi
lipid
constitut
essenti
compon
virion
matur
zikv
particl
contain
lipid
weight
lipid
molecul
total
arrang
lipid
bilay
constitut
viral
envelop
given
zikv
encod
machineri
necessari
lipid
synthesi
lipid
deriv
host
cell
membran
specif
lipid
envelop
zikv
hijack
membran
endoplasm
reticulum
er
genom
replic
particl
biogenesi
coupl
analysi
lipid
envelop
relat
flaviviru
wnv
indic
specif
lipid
sort
necessari
flaviviru
morphogenesi
virion
enrich
sphingolipid
sphingomyelin
reduc
level
phosphatidylcholin
import
featur
zikv
share
plusstrand
rna
virus
replic
associ
mark
rearrang
cytoplasm
membran
actual
zikv
viru
replic
virusinduc
membran
factori
organ
special
portion
er
undergo
membran
invagin
contain
porelik
open
toward
cytosol
structur
similar
vesicl
packet
vp
develop
cell
infect
denv
wnv
sens
alter
lipid
metabol
impair
flaviviru
genom
replic
virion
biogenesi
provid
interest
strategi
antivir
intervent
see
section
membran
associ
zikv
nonstructur
protein
import
viral
replic
fact
multipass
transmembran
protein
accordingli
proper
biogenesi
membran
associ
requir
zikv
replic
addit
activ
cofactor
proteas
must
also
anchor
viral
proteas
er
mention
major
hostinteract
protein
function
flavivir
replic
pathogenesi
immun
evas
also
associ
cellular
membran
despit
lack
transmembran
domain
import
featur
zikv
share
plusstrand
rna
virus
replic
associ
mark
rearrang
cytoplasm
membran
actual
zikv
viru
replic
virusinduc
membran
factori
organ
special
portion
er
undergo
membran
invagin
contain
porelik
open
toward
cytosol
structur
similar
vesicl
packet
vp
develop
cell
infect
denv
wnv
sens
alter
lipid
metabol
impair
flaviviru
genom
replic
virion
biogenesi
provid
interest
strategi
antivir
intervent
see
section
membran
associ
zikv
nonstructur
protein
import
viral
replic
fact
multipass
transmembran
protein
accordingli
proper
biogenesi
membran
associ
requir
zikv
replic
addit
activ
cofactor
proteas
must
also
anchor
viral
proteas
er
mention
major
hostinteract
protein
function
flavivir
replic
pathogenesi
immun
evas
also
associ
cellular
membran
despit
lack
transmembran
domain
apart
lipid
contain
er
membran
lipid
cellular
structur
peroxisom
lipid
droplet
also
relat
zikv
infect
sever
zikv
protein
interact
protein
associ
peroxisom
lipid
transfer
er
peroxisom
vapa
vapb
viral
local
peroxisom
transient
express
suffici
alter
peroxisom
morpholog
distribut
analysi
zikvinfect
patient
also
reveal
increas
level
phosphatidylethanolamin
plasmalogen
synthesi
plasmalogen
depend
upon
function
peroxisom
support
role
organel
zikvinfect
import
peroxisom
viru
biolog
extend
result
observ
viral
model
influenza
viru
herp
virus
consid
peroxisom
play
import
role
lipid
metabol
innat
immun
connect
zikv
infect
could
constitut
interest
target
suitabl
antivir
intervent
anoth
exampl
depend
zikv
replic
cellular
structur
link
lipid
metabol
relat
lipid
droplet
document
capsid
c
protein
zikv
local
lipid
droplet
associ
abolish
specif
amino
acid
substitut
apart
lipid
contain
er
membran
lipid
cellular
structur
peroxisom
lipid
droplet
also
relat
zikv
infect
sever
zikv
protein
interact
protein
associ
peroxisom
lipid
transfer
er
peroxisom
vapa
vapb
viral
local
peroxisom
transient
express
suffici
alter
peroxisom
morpholog
distribut
analysi
zikvinfect
patient
also
reveal
increas
level
phosphatidylethanolamin
plasmalogen
synthesi
plasmalogen
depend
upon
function
peroxisom
support
role
organel
zikvinfect
import
peroxisom
viru
biolog
extend
result
observ
viral
model
influenza
viru
herp
virus
consid
peroxisom
play
import
role
lipid
metabol
innat
immun
connect
zikv
infect
could
constitut
interest
target
suitabl
antivir
intervent
anoth
exampl
depend
zikv
replic
cellular
structur
link
lipid
metabol
relat
lipid
droplet
document
capsid
c
protein
zikv
local
lipid
droplet
associ
abolish
specif
amino
acid
substitut
c
protein
although
consequ
associ
yet
deciph
could
import
virion
biogenesi
describ
denv
point
also
mention
zikvinfect
modul
cellular
autophagi
presum
via
cleavag
cellular
factor
express
interact
zikv
autophag
pathway
seem
complex
data
posit
neg
effect
autophagi
viru
controversi
probabl
depend
cell
type
studi
support
posit
role
autophagi
infect
also
studi
support
idea
cholesterol
deriv
activ
autophagi
also
reduc
infect
discrep
reinforc
need
better
understand
function
connect
lipid
autophagi
zikv
infect
relat
denv
modul
cellular
autophagi
infect
cell
provid
anoth
connect
lipidenergi
metabol
membran
remodel
viru
product
overal
data
suggest
flavivirus
like
zikv
depend
differ
aspect
lipid
metabol
complet
life
cycl
ideal
could
exploit
identifi
suitabl
hda
depend
lipid
synthesi
flaviviru
infect
extens
document
revis
specif
confirm
zikv
take
account
observ
hypothes
downregul
lipid
synthesi
use
hypolipidem
agent
could
reduc
zikv
infect
accordingli
sever
structurallyunrel
inhibitor
sterol
regulatori
elementbind
protein
srebp
pathway
major
regul
lipid
metabol
reduc
zikvinfect
cultur
cell
compound
name
nordihydroguaiaret
acid
ndga
methyl
deriv
tetraomethyl
nordihydroguaiaret
acid
n
fatostatin
tabl
could
constitut
lead
compound
develop
antivir
therapi
zikv
interestingli
srebp
inhibitor
also
inhibit
multipl
relat
wnv
denv
hepat
c
viru
anoth
member
famili
flavivirida
show
potenti
broadspectrum
antivir
therapi
base
inhibit
lipid
metabol
moreov
antivir
potenti
srebpdepend
lipidom
reprogram
also
explor
taxonom
distant
virus
middl
east
respiratori
syndrom
coronaviru
influenza
viru
anoth
exampl
lipid
metabol
modul
exhibit
antizikv
activ
provid
activ
adenosin
monophosphateactiv
protein
kinas
ampk
one
main
cellular
energi
sensor
regul
glycolysi
lipid
metabol
ampk
activ
show
antizikv
activ
includ
specif
small
molecul
compound
like
indirect
activ
like
metformin
ribonucleotid
aicar
tabl
activ
ampk
use
compound
also
inhibit
infect
denv
wnv
confirm
broadspectrum
antivir
potenti
kind
drug
result
use
seri
smallmolecul
inhibitor
tabl
acetylcoenzym
carboxylas
acc
key
enzym
fatti
acid
metabol
support
role
lipid
metabol
specif
fatti
acid
synthesi
zikv
denv
wnv
infect
one
inhibitor
undergon
clinic
trial
healthi
volunt
treatment
diabet
mellitu
test
wnv
mous
model
show
reduct
viremia
viral
load
kidney
suggest
potenti
compound
treatment
flaviviru
diseas
interestingli
activ
acc
directli
regul
ampk
phosphoryl
ampk
inhibit
acc
enzymat
activ
phosphoryl
serin
thu
ampkacc
tandem
could
constitut
major
druggabl
target
antivir
intervent
zikv
relat
flavivirus
sphingolipid
constitut
lipid
class
defin
presenc
longchain
amino
alcohol
sphingosin
sphingolipid
specif
sphingomyelin
particularli
abund
nervou
tissu
lipid
play
import
role
cellular
physiolog
diseas
associ
divers
step
flaviviru
infect
vitro
vivo
use
anim
model
case
zikv
recent
report
shown
infect
human
fetal
astrocyt
reduc
treatment
tabl
specif
inhibitor
neutral
enzym
catalyz
convers
sphingomyelin
ceramid
studi
extend
previous
report
antiflavivir
effect
drug
wnv
usutu
viru
highlight
potenti
broadspectrum
hda
target
lipid
metabol
flaviviru
infect
cholesterol
involv
key
step
entri
membran
fusion
innat
immun
virion
biogenesi
import
cholesterol
zikv
infect
extend
mosquito
vector
instanc
insect
parasit
bacteria
wolbachia
modul
hostcel
lipid
disrupt
cholesterol
vesicular
traffick
block
denv
zikv
life
cycl
consid
depend
cellular
cholesterol
zikv
infect
statin
class
inhibitor
cholesterol
biosynthesi
target
hydroxymethylglutaryl
coa
reductas
hmgcoa
reductas
key
enzym
cholesterol
biosynthesi
propos
potenti
antivir
candid
zikv
howev
potenti
cholesterol
pharmacolog
target
zikv
restrict
use
biosynthesi
inhibitor
recent
report
point
cholesterol
transport
druggabl
target
combat
zikv
interfer
cholesterol
traffick
use
imipramin
tabl
inhibit
replic
zikv
flavivirus
later
studi
confirm
hypothesi
show
benzamil
tabl
inhibitor
membran
transport
cholesterol
also
reduc
zikvinfect
thank
bioactiv
properti
cholesterol
deriv
could
also
constitut
therapeut
weapon
fight
zikv
product
tabl
mediat
protect
zikv
infect
microcephali
anim
model
mechan
action
seem
relat
immunostimulatori
effect
reduc
inflamm
cell
death
caus
zikv
infect
directli
block
viral
entri
thu
rise
interest
candid
zikv
therapeut
base
safeti
abil
cross
bbb
anoth
cholesterol
deriv
exhibit
antizikv
activ
neuron
tabl
case
propos
mechan
inhibit
zikv
infect
like
relat
induct
cellular
autophagi
compound
daptomycin
lipopeptid
antibiot
insert
cell
membran
rich
phosphatidylglycerol
also
describ
zikv
inhibitor
final
although
review
focus
therapeut
opportun
discoveri
hda
zikv
relat
lipid
metabol
note
lipid
contain
zikvenvelop
structur
compon
virion
also
provid
suitabl
target
develop
daa
exampl
treatment
extract
aphloia
theiformi
edibl
plant
damag
zikv
virion
deform
viral
shape
affect
viral
entri
consist
lipid
envelop
antivir
disrupt
appear
complementari
antivir
strategi
inhibit
zikv
small
molecul
amphipath
peptid
also
disrupt
virion
envelop
reduc
zikvinfect
importantli
latter
also
exhibit
therapeut
effect
infect
mice
show
potenti
novel
antivir
strategi
mention
strategi
inhibit
zikv
infect
provid
experiment
proofofconcept
feasibl
strategi
target
lipid
combat
viral
infect
howev
import
note
studi
still
initi
stage
mainli
base
infect
perform
cell
cultur
remark
limit
vivo
experi
also
support
viabil
kind
approach
therapeut
intervent
case
peptid
disrupt
viral
envelop
although
could
seem
riski
think
antivir
strategi
base
lipid
metabol
constitut
one
key
cellular
metabol
pathway
import
rememb
lipid
metabol
actual
first
order
pharmaceut
target
treatment
human
disord
srebp
ampk
antivir
target
alreadi
valid
zikv
current
constitut
import
pharmacolog
target
human
diseas
obes
metabol
syndrom
type
ii
diabet
cancer
drug
undergon
divers
phase
clinic
trial
other
even
licens
human
use
instanc
metformin
indirect
ampk
activ
drug
licens
human
constitut
one
commonli
prescrib
drug
treatment
diabet
support
safeti
kind
approach
treatment
human
ill
sphingomyelin
metabol
modul
specif
inhibitor
sphingomyelin
ceramid
convers
also
constitut
therapeut
target
current
evalu
likewis
drug
target
cholesterol
biosynthesi
ie
statin
commonli
prescrib
treatment
cardiovascular
diseas
provid
exampl
safeti
therapeut
success
drug
interfer
lipid
metabol
sens
imipramin
inhibit
zikv
infect
alter
cholesterol
traffic
antidepress
also
approv
human
use
provid
addit
exampl
lipid
modul
abil
cross
bbb
could
use
treatment
zikv
consid
data
support
antivir
potenti
lipidbas
antivir
strategi
come
cell
cultur
small
anim
model
could
interest
test
reliabl
strategi
real
world
could
initi
address
take
advantag
lipidlow
drug
alreadi
licens
ie
statin
metformin
imipramin
end
epidemiolog
survey
patient
cohort
zikvendem
region
could
perform
virolog
viremia
viral
load
urin
sever
infect
biolog
paramet
relat
lipid
metabol
serum
lipid
profil
biomark
sever
infect
relat
denv
potenti
includ
analys
anoth
import
point
taken
consider
drug
target
lipid
metabol
review
effect
one
flaviviru
confirm
broadspectrum
potenti
flavivirus
constitut
neglect
human
pathogen
complic
develop
specif
antivir
strategi
reposit
drug
target
lipid
metabol
antivir
candid
could
lead
afford
broadspectrum
compound
although
util
antivir
combat
zikv
infect
especi
pregnant
women
rais
multipl
safeti
concern
note
could
use
treatment
infect
patient
prevent
zikvassoci
ill
even
effect
antivir
treatment
lower
viral
load
use
prevent
zikv
transmiss
diminish
risk
mosquito
infect
bloodfeed
reduc
viral
burden
reproduct
system
infect
patient
could
therefor
also
block
sexual
transmiss
viru
import
remark
antivir
effect
exert
compound
target
lipid
metabol
infect
model
use
strong
show
reduct
log
viru
product
still
cautiou
relev
drug
advanc
studi
nevertheless
lipidtarget
drug
could
ideal
util
alon
also
combinatori
therapi
togeth
antivir
ie
daa
provid
anoth
weapon
arsen
combat
zikv
case
although
long
way
yet
complet
implement
antivir
strategi
clinic
practic
current
scenario
potenti
benefit
support
futur
research
effort
aim
reposit
lipid
metabol
modul
antivir
compound
author
declar
conflict
interest
